How did ALX Oncology's expenses trend in Q4 2024?

In Q4 2024, ALX Oncology's Research and Development (R&D) expenses were $23.53 million. |code|Ticker|Name|Date|R&D Expenses|market_code| |---|---|---|---|---|---| |ALXO|ALXO.O|ALX Oncology|2024 Q1|3.1717E7|185| |ALXO|ALXO.O|ALX Oncology|2024 Q2|3.4653E7|185| |ALXO|ALXO.O|ALX Oncology|2024 Q3|2.6471E7|185| |ALXO|ALXO.O|ALX Oncology|2024 Q4|2.3532E7|185|